T1	Participants 38 93	cancer patients enrolled in a smoking cessation program
T2	Participants 112 127	cancer patients
T3	Participants 464 565	246 cancer patients participating in a randomized placebo-controlled smoking cessation clinical trial
T4	Participants 1750 1764	ancer patients
T5	Participants 1420 1477	Patients with tobacco-related cancers and female patients
